Streetbeat News

Stock Prices

OBLG

Oblong Inc. (NASDAQ:OBLG) reported a significant decrease in sales for Q4, with revenues falling to $944.00 thousand from $1.43 million in the same quarter last year, marking a 33.80% decline.

Portfolio Pulse from Happy Mohamed

March 19, 2024 | 8:35 pm

TSHA

Taysha Gene Therapies (NASDAQ:TSHA) reported Q4 earnings with an EPS of $0.92, beating estimates by 936% and showing a revenue increase of $1.10 million from the previous year. Despite past earnings misses, the company's share price increased by 26% following the last quarterly report.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 8:35 pm

SBUX

Over the past 20 years, Starbucks (NASDAQ:SBUX) has produced an average annual return of 12.17%, outperforming the market by 4.19% annually. A $100 investment in SBUX 20 years ago would now be worth $982.46. Starbucks currently has a market capitalization of $103.70 billion.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 8:31 pm

TSHA

Taysha Gene Therapies shares surged following the announcement of an increase in their FY23 EPS results compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:25 pm

PGEN

Precigen (NASDAQ:PGEN) reported Q4 earnings with an EPS of $-0.13, missing estimates by -62.0% against an expected $-0.08. Revenue decreased by $535 thousand compared to the same period last year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 13.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 8:25 pm

SHOT

Safety Shot, symbol SHOT, experienced a significant increase in its share price following a legal victory against Capybara Research and Igor Appelboom. The lawsuit's win is likely to positively impact investor sentiment and the company's reputation.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:22 pm

BUD

MO

Altria has initiated $2.4 billion in accelerated share repurchase transactions following the closure of its offering of Anheuser-Busch InBev stock. This move is part of Altria's strategy to return value to its shareholders.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:17 pm

WULF

TeraWulf (NASDAQ:WULF) reported Q4 earnings with an EPS of $-0.03, missing estimates by -50.0% against an expected $-0.02. Revenue increased by $13.69 million from the same period last year. The company's past earnings performance shows a pattern of missing EPS estimates, which previously led to a 5.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 8:15 pm

GTLB

GitLab Inc (NASDAQ:GTLB) reported upbeat Q4 results but faced mixed 2025 outlook pressures. KeyBanc Capital Markets views GitLab as a key beneficiary of the DevSecOps platform expansion, with a total addressable market over $120 billion. Analyst Jason Celino maintains an Overweight rating with a $70 price target, citing potential for growth acceleration driven by gen AI and GitLab Duo. GitLab's shares slightly rose to $55.29.

Portfolio Pulse from Priya Nigam

March 19, 2024 | 8:14 pm

CJJD

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) has regained compliance with the Nasdaq minimum bid price requirement after its stock price remained at or above $1.00 for 10 consecutive business days. This follows a 1-for-20 reverse stock split effective March 1, 2024, which was part of the company's efforts to meet Nasdaq's listing standards after initially failing to maintain the minimum bid price in June 2023.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 8:12 pm